DRUG - Balance Sheet - Bright Minds Biosciences Inc.

Current Liabilities	529 K
Accounts Payable	408 K
Short-Term Debt	79.4 K
Other Current Liabilities	41.8 K
Non-Current Liabilities	39.6 K
Long-Term Debt	39.6 K
Other Non-Current Liabilities	0

Millions

	Sep-2024	Sep-2023	Sep-2022	Sep-2021	Sep-2020	Sep-2019
ASSETS
Cash & Cash Equivalents	5.7	6.7	11.6	19.8	0.8	80 K
Short Term Investments	0	86.2 K	86.2 K	86.2 K	0	0
Receivables	50.2 K	0	0.2	0.1	0	0
Inventory	0	0	0	0	0	0
Other Current Assets	0.2	27.7 K	0.2	0.2	78.3 K	0
Total Current Assets	6.0	6.8	11.9	20.0	0.9	80 K
PP&E	0.1	66.4 K	0.1	0	0	0
Intangible Assets	0	0	0	2	2	2 K
Goodwill	0	0	0	2 K	2 K	0
Long Term Investments	0	0	0	33.7 K	1 K	82 K
Other Long Term Assets	0	0	0	33.7 K	1 K	0
Other Assets	0	0	0	0	0	0
Total Assets	6.1	6.9	12.1	20.0	0.9	0.2
LIABILITIES
Accounts Payable	0.4	0.2	1.2	0.6	0.1	36.7 K
Short Term Debt	79.4 K	73.5 K	67.9 K	0	0	0
Other Current Liabilities	41.8 K	25 K	0.2	42 K	12.5 K	0
Total Current Liabilities	0.5	0.3	1.5	0.6	0.2	36.7 K
Long Term Debt	39.6 K	0	72 K	0	0	0
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	0	0	0	0	0	0
Total Liabilities	0.6	0.3	1.5	0.6	0.2	36.7 K
EQUITY
Common Stock	35.4	33.9	32.2	27.1	1.0	0.2
Retained Earnings	(34.3)	(31.5)	(24.2)	(9.2)	(0.6)	78.7 K
Other Accumulative Comprehensive Income/Loss	4.0	3.4	2.5	1.6	0.2	82 K
Total Equity	5.5	6.6	10.5	19.4	0.7	0.1
Total Liabilities and Equity	6.1	6.9	12.1	20.0	0.9	0.2
SHARES OUTSTANDING
Common Shares Outstanding	3.7	2.5	1.8	1.3	1.3

Free